What Implicity does
Implicity provides an AI-powered platform that unifies remote monitoring data from implantable cardiac devices made by Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort into one dashboard. The company says its FDA-cleared algorithms filter alerts and reduce false positives, and that use of the platform is associated with a 26% reduction in mortality and shorter hospitalizations compared with conventional remote monitoring. It serves cardiologists, care teams, and billing staff, and its products include an ECG analyzer, a predictive heart-failure alert tool, and atrial-fibrillation alert management.
Implicity is a healthcare tool on Falcoscan. AI platform that centralizes and triages remote cardiac implant monitoring data. Falcoscan rates Implicity with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: hot. Implicity is founded in 2016, currently at Growth stage. Pricing: Paid.